News Article | March 1, 2017
MORRISTOWN, NJ, March 01, 2017-- Dr. Jason E. Lowenstein, a Board Certified Morristown, NJ physician specializing in Orthopaedic Surgery, has been selected by Castle Connolly Medical Ltd. for inclusion in its authoritative guide to the top primary care and specialty care doctors in the tri-state metropolitan New York area.Morristown, NJ February 28, 2017-- Castle Connolly Medical Ltd., America's trusted source for identifying Top Doctors, has published the 15th edition of Top Doctors: New York Metro Area and has selected Jason E. Lowenstein, MD for this exclusive honor.The 15th edition of Top Doctors: New York Metro Area includes over 5,500 top primary care and specialty care physicians in a twenty-county area spanning three states: New York, New Jersey and Connecticut. Selected physicians, including Dr. Lowenstein, represent the top 10% of doctors in the area in 65 medical specialties and subspecialties for the care and treatment of more than 1,800 diseases and medical conditions.Castle Connolly Top Doctors are selected each year by Castle Connolly Medical Ltd. after being nominated by their peers in an online nomination process. Nominations are open to all board certified MDs and DOs and each year tens of thousands of physicians cast many tens of thousands of nominations. Nominated physicians are selected by the Castle Connolly physician-led research team based on criteria including medical education, training, hospital appointments, disciplinary histories and much more.About Jason E. Lowenstein:Dr. Jason E. Lowenstein is a board-certified, fellowship-trained, Adult and Pediatric Spine Surgeon. He is the Director of the Scoliosis and Spinal Deformity Center at Morristown Medical Center, and is a partner at The Advanced Spine Center in Morristown, NJ. ( www.theadvancedspinecenter.com ) Dr. Lowenstein specializes in the treatment of Spinal Deformity in children and adults, including Scoliosis, Kyphosis, and Spondylolisthesis, Disc Herniations and Stenosis of the Cervical, Thoracic, and Lumbar spine, Complex Revision Surgery for Failed Back Syndrome, and Minimally Invasive Spine Surgery.For more information on this Castle Connolly New York Metro Area Top Doctor , please visit Jason E. Lowenstein's profile on www.castleconnolly.com Castle Connolly Medical Ltd.'s President and CEO Dr. John Connolly has this to say about Dr. Lowenstein's recognition: "Roughly ten percent of area physicians were selected for our 15th edition of Top Doctors: New York Metro Area. Being nominated by Board Certified peers and then selected by our experts is an accomplishment worthy of recognition. The New York Metro area is home to a great number of very high quality medical professionals, yet some stand out. My congratulations to Dr. Lowenstein."To find out more or to contact Dr. Jason E. Lowenstein of Morristown, NJ, please call (973) 538-0900 or visit www.jasonlowensteinmd.com and/or www.theadvancedspinecenter.com This press release was written by American Registry, LLC and Castle Connolly Medical Ltd., with approval by and/or contributions from Jason E. Lowenstein.Castle Connolly Medical Ltd. identifies top doctors in America and provides consumers with detailed information about their education, training and special expertise in printed guides and online directories. It is important to note that doctors do not and cannot pay to be included in any Castle Connolly guide or online directory. Learn more at http://www.castleconnolly.com American Registry, LLC, recognizes excellence in top businesses and professionals. For more information, search The Registry at http://www.americanregistry.com
News Article | February 15, 2017
RALEIGH, NC, February 15, 2017 /24-7PressRelease/ -- Daniel J. Albright, MD announced that he has performed two-level cervical disc replacement procedures utilizing a novel medical device recently approved by the FDA. The procedure was one of the first of its kind in the Raleigh North Carolina area. The device, the first and only cervical disc replacement FDA approved for both one and two-level applications was the subject of a rigorous FDA Investigational Device Exemption (IDE) trial. In the study, the two-level cervical disc replacement procedure demonstrated an overall study success rate of 69.7% as compared to traditional cervical fusion results of 37.4%. At 24 months, those who received the two-level cervical disc replacement during the trial phase also returned to work on average three weeks earlier as compared to those patients who were treated with cervical fusion. The disc replacement patients also had lower rates of subsequent surgeries and reduced rates of ongoing degeneration at spinal segments adjacent to the surgery. "I am very proud to be able to offer my patients this state of the art procedure which is supported by the highest level of medical evidence available for a medical device," said Dr. Albright, of Raleigh Orthopedics. "And for the first time I am able to offer the significate number of my patients who suffer from two-level cervical disease a superior treatment option to traditional cervical spine fusion." About Daniel Albright, MD Daniel J Albright, MD is a board certified orthopedic surgeon, who completed two fellowships in spine surgery and total hip and knee replacements. Dr. Albright joined Raleigh Orthopaedic Clinic in 1994. Dr. Albright completed his undergraduate degree at Dartmouth College in Hanover, New Hampshire, and attended Louisiana State School of Medicine in New Orleans. He completed his residency in orthopedic surgery at Yale-New Haven Hospital. Following residency, Dr. Albright obtained additional training in Spine Surgery at St. Luke's Medical in Cleveland, Ohio, and Knee & Hip Replacement and Revision Surgery at Massachusetts General Hospital.
News Article | February 15, 2017
Driving educational, scientific and medical cooperation for excellence in health care 15/Feb/2017 Tanzania: In an ongoing pursuit of delivering paramount medical services and health care facilities to the African nations, India (New Delhi) based BLK Super Speciality Hospital has announced signing of a Memorandum of Understanding (MoU) with Muhimbili Orthopaedic Institute (MOI), which is one of the largest orthopaedic hospitals in Tanzania. The pact would help promote cooperation and mutual understanding between the two countries. BLK Super Speciality Hospital has been extending medical services in Tanzania in the past as well. The hospital has also signed a similar pact with The Jakaya Kikwete Cardiac Institute (JKCI) in 2015. Doctors from BLK Super Speciality Hospital have been regularly visiting Tanzania offering multiple speciality care and services along with surgical interventions in the region. This strategic partnership with MOI will ensure quality medical consultation and management of the patients for specialised services. Talking on the pact with MOI, Mr. Naresh Kapoor, Executive Director, BLK Super Speciality Hospital, said, “We are happy to extend medical support in different parts of the world and with this partnership, we shall assist MOI achieve its objective of becoming a preferred and advanced healthcare destination for the people of Tanzania and the East African region by knowledge sharing, transfer of skills and capacity building. The pact will also allow our doctors and technical experts, to periodically visit and train MOI’s medical staff keeping them abreast with the latest developments in medical sciences.” “This partnership aims to set up a platform for both the hospitals enabling each to share their experiences and expertise. The two institutions in particular will develop educational, scientific and medical cooperation through surgical camps, workshops, observerships and Continuing Medical Education (CME) programmes” added Mr Kapoor. Dr. Othman, Executive Director, Muhimbili Orthopaedic Institute, said, “It is a matter of privilege for us to collaborate with BLK Super Speciality Hospital, which is one of the largest hospitals in Delhi NCR with 650 beds. This pact shall give us opportunities to develop and establish our institute as the leading and advanced healthcare destination for our people. The MoU shall also pave the way for strengthening our pre and post-operative patients care through exchange programs. We see this as a great opportunity to learn from each other’s strengths and is a progressive step forward for cultural exchange.” Senior and eminent doctors like Dr. Puneet Giridhar, Director - Spine Surgery, BLK Centre for Orthopaedics and Spine Surgery and Dr Subhash Chandra, Chairman & HoD, Cardiology, BLK Heart Centre from BLK Super Speciality Hospital will visit Tanzania from 13th to 15th February. During their visit they will perform Orthopaedic and Cardiac surgical interventions. Dr Puneet Girdhar will perform interventions like lumbar discectomy, cervical discectomy, thoracolumbar spinal fixation, disc replacement and spinal stabilization or fusion surgery at MOI, while Dr. Subhash Chandra will perform various cardiac procedures including Peripheral Angioplasties, Coronary Angioplasties and Balloon Mitral Valvoplasties or Valvotomies at JKCI. About BLK Super Speciality Hospital BLK Super Speciality is one of the largest private hospitals in the National Capital Region (NCR) of Delhi with a capacity of 650 beds including 140 critical care beds. The outpatient services are spread over two floors with 57 consultation rooms. All ambulatory services are smartly designed to ensure quick access to interventional services. The Hospital has 17 state-of-the-art well equipped modular operation theaters and a world-class pathology lab. The Hospital is equipped with most modern infrastructure, and eminent doctors drive its Centers of Excellence. The hospital has Asia’s largest Bone Marrow Transplant Units. We have deployed very high-end technologies such as Cyberknife VSI, TriologyTxLinear Accelerator, Bi Plane Neuro Interventional lab which are geared to address complex medical needs of patients. Our infrastructure and services stand testimony to BLK’s philosophy of A Passion for Healing. The hospital is owned and managed by Radiant Life Care, which also manages Mumbai’s iconic Nanavati Super Speciality Hospital. For more information please contact: Seema Choudhary firstname.lastname@example.org +91 869 289 2550
News Article | February 28, 2017
First Choice PT/OT Centers on Florida's Space Coast to Increase from One to Five in 2017 to Meet Robust Demand from Its Growing Orthopaedic and Spine Medical Practices MELBOURNE, FL--(Marketwired - Feb 28, 2017) - First Choice Healthcare Solutions, Inc. ( : FCHS) ("FCHS," "First Choice" or the "Company"), one of the nation's only non-physician-owned, publicly traded healthcare services companies focused on the delivery of total musculoskeletal solutions with an emphasis on Orthopaedics and Spine care, today announced that Steve Ryland, PT, DPT has been appointed to serve as the Company's Director of Physical/Occupational Therapy ("PT/OT"). In this role, Dr. Ryland will oversee the PT/OT Division and implement key expansion initiatives that will increase the number of First Choice-owned and operated, state-of-the-art PT/OT centers serving Florida's high growth Space Coast service region from one to five centers in 2017 -- with the second and third centers slated to open in March and the fourth and fifth center slated to open shortly thereafter. The new First Choice PT/OT centers will be strategically located throughout the service region, currently spanning 72 miles north to south on Florida's central east coast. As the volume of both surgical and non-surgical patients served by First Choice's Medical Centers of Excellence in Brevard County have continued to increase through employment of additional world class physicians, so, too, has demand grown for best-in-class physical and occupational therapy services for thousands of First Choice patients. Whether prescribed for rehabilitation after a hip, shoulder or knee replacement or spinal fusion, or prescribed as conservative therapeutic care for a musculoskeletal condition or injury, PT/OT is a vital component of achieving optimal care outcomes for patients; and in many cases, PT may be mandated by a medical insurance payer prior to surgical remedies being pursued. According to Kris Jones, First Choice's Vice President of Medical Operations, "Our surgical and non-surgical Orthopaedic and Spine patients each require, on average, a PT/OT regimen of 10 treatment sessions with qualified therapists to achieve the best possible outcomes. Considering that the Space Coast service region covers such a broad geographic footprint, to help ensure compliance with prescribed rehabilitative treatment, our physicians and surgeons were having to refer patients to other PT/OT providers. With our planned geographic expansion and leveraging Dr. Ryland's expertise and leadership, not only will First Choice maintain payer compliance with PT/OT mandates, but more importantly, we will be able to provide all of our patients requiring rehabilitation with optimal choice and travel convenience while retaining management and control of their full episodes of care -- from diagnosis to treatment to recovery." Similar to First Choice's current PT/OT center located in Melbourne, each new PT/OT center will be equipped with the industry's most advanced rehabilitation equipment and staffed by the region's best-in-class physical and occupational therapists and care specialists. Once all First Choice PT/OT centers are operational, they will have total capacity to administer up to 85,000 patient visits each year, generating up to $8 million in annual revenues. Prior to joining First Choice, Dr. Ryland was the founder of a very successful PT company, which operated five out-patient physical therapy clinics in Brevard County, Florida for over 15 years. After receiving a Bachelor's degree in Economics and International Affairs from Florida State University and a Bachelor's degree in Physical Therapy from the University of Central Florida, he earned his Doctorate in Physical Therapy from Boston University. Specializing in acute care, sub-acute rehabilitation, outpatient Orthopaedics and home health care, he has also provided preventative care and training to elite and professional athletes, including members of the Ladies Professional Golf Association and the Washington Nationals professional baseball organization. Since forming his private PT practice in 2002, Dr. Ryland has consulted several leading PT providers and business owners across the U.S. on building successful PT/OT practices through effective management systems and techniques. Commenting on this key appointment, Chris Romandetti, Chairman, President and CEO of First Choice, said, "We are very pleased to welcome Dr. Ryland to First Choice and look forward to tapping his industry expertise and experience in building world class care facilities focused on achieving optimal outcomes for patients requiring physical rehabilitation. We believe he is the ideal choice for spearheading this exciting new growth initiative for our Company, and expect that our PT/OT division's future success will be positively and measurably impacted by his proven leadership." Dr. Ryland added, "First Choice is widely viewed to be one of the most exciting, high growth healthcare companies on the Space Coast, which is succeeding at advancing the quality of care offered to patients who live, work and visit this area. It was clear from the start that everyone at First Choice shares my passion for establishing entirely new standards of excellence in healthcare, so I'm thrilled to be joining their impressive team. Moreover, I consider it a privilege to be taking the lead in helping the Company to manage and grow its physical and occupational therapy group and expect to make fast work of helping them to build this division into a significant contributor to its annual revenue and earnings growth." In closing, Jones added, "The addition of Dr. Ryland and multiple new PT/OT locations is a true testament to our team's dedication and commitment to best-in-class patient treatment and full continuity of care -- for that I am immensely proud and grateful." About First Choice Healthcare Solutions, Inc. Headquartered in Melbourne, Florida, First Choice Healthcare Solutions (FCHS) is implementing a defined growth strategy aimed at expanding its network of non-physician-owned medical centers of excellence, which concentrate on treating patients in the following specialties: Orthopaedics, Spine Surgery, Neurology, Interventional Pain Management and related diagnostic and ancillary services in key expansion markets throughout the Southeastern U.S. Serving Florida's Space Coast, the Company's flagship integrated platform currently administers over 100,000 patient visits each year and is comprised of First Choice Medical Group, The B.A.C.K. Center and Crane Creek Surgery Center. For more information, please visit www.myfchs.com, www.myfcmg.com, www.thebackcenter.net and www.cranecreeksurgerycenter.com. Safe Harbor Statement Certain information set forth in this news announcement may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of First Choice Healthcare Solutions, Inc. Such forward-looking statements are based on current expectations, estimates and projections about the Company's industry, management beliefs and certain assumptions made by its management. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Information concerning factors that could cause the Company's actual results to differ materially from those contained in these forward-looking statements can be found in the Company's periodic reports on Form 10-K and Form 10-Q, and in its Current Reports on Form 8-K, filed with the Securities and Exchange Commission. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise to reflect future events or circumstances or reflect the occurrence of unanticipated events.
News Article | February 28, 2017
BIOSPHERE PUTTY, dat oorspronkelijk in 2013 in de VS is geïntroduceerd, is een synthetisch bottransplantatieproduct dat gebruik maakt van bioactief glas in een unieke vorm, in combinatie met een kneedbare fosfolipide-drager. BIOSPHERE PUTTY is gebaseerd op de gepatenteerde BioSphere-technologie van het bedrijf. Het is in vivo aangetoond dat de bolvorm en de geoptimaliseerde, bimodale groottes van de bioactieve glasdeeltjes het herstelvermogen van het materiaal significant verbeteren. “BIOSPHERE PUTTY is sinds de introductie heel goed ontvangen door chirurgen, vanwege het succesvolle klinische gebruik en de uitstekende hanteerbaarheid tijdens het opereren,” verklaarde dr. Mark Borden, Ph.D., President/CEO of Synergy. “We zijn blij met onze CE-markering en zien ernaar uit dit synthetische bottransplantatieproduct van een werkelijk nieuwe generatie te introduceren in de Europese Gemeenschap.” BIOSPHERE PUTTY is in Europa goedgekeurd voor gebruik als bottransplantatiemateriaal voor het opvullen van botholtes of leemtes van het skelet. Dit omvat het gebruik van het product voor interbody- en posterolaterale fusie en als algemene vulling bij botdefecten in de ledematen en het bekken. Het product kan alleen of in combinatie met autogene of allogene transplantaten worden gebruikt . “Bij het kiezen van de beste bottransplantatiestrategie voor elke patiënt zijn er tal van opties voor chirurgen. BIOSPHERE PUTTY is een elegante oplossing voor bottransplantaties op basis van wetenschappelijk aanvaarde principes,” aldus Erik Westerlund MD, FACS, Director Ortho-Neuro Integrated Spine Surgery Program van het St. Francis Hospital in de VS. “Dankzij een diep en geavanceerd inzicht in bioactief glas wordt een doelbewuste respons op celniveau teweeggebracht en een ideale fysieke omgeving gecreëerd voor een gelijkmatige en voorspelbare botingroei. Mijn klinische ervaring met BIOSPHERE PUTTY in de afgelopen twee jaar is uitstekend, met succesvolle langetermijnresultaten in zeer uiteenlopende toepassingen in de wervelkolom. Het is een uiterst doordachte en veelzijdige oplossing voor bottransplantaties.” BIOSPHERE PUTTY is de eerste in een reeks door Synergy Biomedical te ontwikkelen bottransplantatieproducten die gebruik maken van gepatenteerde bolvormige deeltjes bioactief glas waarvan is aangetoond dat ze het herstelvermogen van het materiaal verbeteren. BIOSPHERE PUTTY biedt chirurgen een kneedbaar bottransplantatiemateriaal dat gemakkelijk te gebruiken is en geschikt is voor zeer uiteenlopende bottransplantatietechnieken. Synergy Biomedical is opgericht in 2011. Het is een particuliere onderneming in medische hulpmiddelen die zich richt op de ontwikkeling van innovatieve producten op basis van biomaterialen voor orthopedische en wervelkolomchirurgie. Met de BioSphere-technologie brengt het bedrijf de bottransplantatietechniek op unieke wijze naar een hoger plan en draagt het bij aan verbetering van de genezing van botten en de resultaten voor patiënten. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is.
News Article | February 28, 2017
COLLEGEVILLE, Pennsylvania--(BUSINESS WIRE)--Synergy Biomedical, LLC, un'azienda che si occupa dello svilupo di prodotti innovativi per l'innesto osseo in ambito di interventi chirugici vertebrali e ortopedici, ha annunciato in data odierna di aver ricevuto l'autorizzazione CE nell'Unione Europea per il suo innesto osseo di prossima generazione: BIOSPHERE PUTTY. In base all'autorizzazione ricevuta dalla CE, l'utilizzo di BIOSPHERE PUTTY è inteso per l'innesto osseo volto a riempire cavità ossee nel sistema scheletrico. Ciò comprende l'utilizzo del prodotto per fusione intersomatica o postero-laterale e riempimento di difetti ossei generici nelle estremità e nell'area pelvica. Il prodotto può essere utilizzato da solo o unitamente ad auto o allotrapianto. “Quando si tratta di selezionare la migliore strategia per l'innesto osseo di un determinato paziente, i chirurghi hanno a disposizione una vasta gamma di opzioni. BIOSPHERE PUTTY è una soluzione elegante per l'innesto osseo basata su principi scientificamente validi", ha commentato Erik Westerlund MD, FACS, direttore dell'Ortho-Neuro Integrated Spine Surgery Program presso il St. Francis Hospital negli USA. “Applica una comprensione avanzata e raffinata del vetro bioattivo per sollecitare una risposta cellulare in maniera mirata e per fornire l'ambiente fisico ideale alla ricrescita uniforme e prevedibile dell'osso. La mia esperienza clinica con BIOSPHERE PUTTY negli ultimi due anni è stata eccellente, con risultati di successo a lungo termine e costanti in un'ampia gamma di applicazioni vertebrali. Si tratta di una soluzione per l'innesto osseo estremamente efficace e versatile". BIOSPHERE PUTTY è il primo di diversi prodotti per l'innesto osseo sviluppati da Synergy Biomedical che utilizzano sfere di vetro bioattivo brevettate dal comprovato potenziale terapeutico del vetro bioattivo. BIOSPHERE PUTTY offre ai chirurghi un materiale modellabile per l'innesto osseo facile da utilizzare e compatibile con una varietà di tecniche per gli innesti ossei.
News Article | February 23, 2017
Advances in patient selection, surgical techniques, and postoperative care over the last two decades have allowed practitioners to manage increasingly complex cases with shorter procedure times and reduced hospital lengths of stay. Building on these successes, AOSpine North America brought together experts to provide a glimpse into the next generation of spine care leading to a supplement in Neurosurgery on the "Future Advances in Spine Surgery." The March 2017 supplement includes an introduction and 13 articles highlighting a range of topics including oncology, deformity, degenerative disease, trauma, infection, and pain. Technological advances such as osteobiologics, robotics, and neuromodulation are discussed in a fascinating series of articles. Also included is a unique study aiming to establish the cost-benefit relationship for spine procedures with perspectives on how value is defined and how to address variability. Each article highlights the salient literature and affords insights from multiple key thought leaders in an effort to minimize bias and provide varied perspectives. As co-editor of this issue and research chair of AOSpine North America, Dr. James Harrop from Thomas Jefferson University explains, "We are very proud of the outstanding contributions from some of the leading spine surgeons of North America that make up this focus issue."
News Article | February 8, 2017
The International Association of HealthCare Professionals is pleased to welcome John R. Barker, MD, Orthopedic Spine Surgeon, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. Dr. John R. Barker is a highly trained and qualified orthopedic spine surgeon with an extensive expertise in all facets of his work. Dr. Barker has been in practice for 16 years and is currently serving patients within the Rocky Mountain Spine Clinic in Lone Tree, Colorado. He is also affiliated with The Medical Center of Aurora and Sky Ridge Medical Center. Dr. John R. Barker attended the University of Oklahoma College of Medicine, graduating with his Medical Degree. He subsequently completed his Orthopaedic Surgery internship and residency at Southern Illinois University College of Medicine, before undertaking his fellowship in Adult & Pediatric Spine Surgery at the Rocky Mountain Spine Clinic. Dr. Barker is board certified in Orthopedic Surgery, and maintains professional memberships with the American Academy of Orthopaedic Surgeons, the North American Spine Society, the Aurora-Adams County Medical Society, the Denver Medical Society, and the Cervical Spine Research Society. He has a special interest in degenerative conditions of the cervical, thoracic, and lumbar spine, scoliosis, spine trauma, spinal tumors, minimally invasive procedures, and total disc arthroscopy. Dr, Barker attributes his success to his excellent training, as well as his interactions with his patients. Learn more about Dr. Barker here: http://www.spineclinic.com/index.php and be sure to read his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics. Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review. FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise. A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life. For more information about FindaTopDoc, visit http://www.findatopdoc.com
News Article | February 18, 2017
World renowned Spine Surgeon, Dr. Richard Francis is widely recognized for being one of the first in the world to use some of the very latest in robotic technology for spine surgery. In 2013 Dr. Francis was one of the first to use the Mazor Renaissance system, the only FDA Approved robot for spine surgery which was the size of a soda can. Now, in 2017, the newest robotic system for spine surgery, the Mazor X System has recently been installed at First Surgical Hospital in Houston Texas. Again, Dr. Francis will be one of the first surgeons to perform spine surgery with this newest robotic technology. Dr. Francis was among the first to use Mazor Robotics technology in the US and has a series of approximately 500 cases over the past 5 years, making him one of the most experienced surgeons in the use of the technology worldwide. Mazor Robotics’ new Mazor X system will allow spine surgeons to use this system for pre-operative analysis prior to a spine operation, for guidance during the surgery and use it for real time 3-D verification during the surgery. The Mazor X system helps the surgeons and their patients by assisting surgeons with a total patient treatment strategy. This robotic technology helps physicians determine a spinal alignment plan before surgery. During the surgery, a bed-attached, bone-mounted surgical arm will help guide the procedure as determined by the pre-operative analytics plan. Finally, 3-D verification during the procedure will use 2-D fluoroscopy-based technology, clearance-pending visual tracking, and intraoperative imaging to give surgeons the feedback needed to ensure the procedure is going as planned. The new system should allow spine surgeons to perform additional procedures like posterial cervical fusions and percutaneous sacroiliac joint fusion, scoliosis corrections, lumbar and thoracic fusions, fracture repairs and revision and trauma surgeries. In recent years since the development of the robotic technology Dr. Francis has also been training other physicians in the use of this new equipment and has facilitated the only robotic spine-surgery training lab offered in Texas for spine surgeons. Dr. Francis has found that robotic assisted spine surgery has been extremely beneficial to his patients, providing a greater accuracy than conventional freehand methods. In addition, patients benefit from lower x-ray exposure, less pain and fewer scars. Patients who have undergone robotic assisted spine surgery have also experienced fewer complications and can return to normal activities more quickly than those whose surgeries were performed by traditional methods. Dr. Francis is one of few spine surgeons capable of performing surgeries on children as well as adults, he is also one of the few surgeons in the nation that performs scoliosis revision surgery and reconstructive surgery on children and adults who have had unsuccessful treatment in the past. Dr. Francis routinely uses minimally invasive surgical techniques which benefit patients by speeding recovery and minimizing post-operative pain, most of which are performed on an outpatient basis so patients typically return home the same day¬¬¬¬ as their procedure is done. Some of the most common surgical procedures Dr. Francis performs include Robotic Assisted Spine Surgery, Artificial Disc Replacement, Minimally Invasive Spine Surgery, Scoliosis Surgery as well as Revision and reconstructive Surgery. There are often complex or multi-factor challenges to an accurate diagnosis of back or neck pain which is why it’s extremely important to see a physician that is specifically trained in spine medicine. Spine Specialists like Dr. Francis with years of very specific expertise in treating all conditions of neck, back and spine are always going to be the best choice for those suffering with chronic pain. Some of the most common conditions treated by Dr. Francis are Sciatica, Neck Pain and Neuropathy, Scoliosis and Spine Deformity in adults and adolescents, Sciatic Nerve Pain, Spinal Stenosis, Degenerative Disc Disease, Herniated Disc, Spinal fractures and Trauma, Failed Back Surgery Syndrome, and Sacroiliac (SI) Joint Pain. As one of the Top Spine Surgeons in the world who is constantly on the cutting edge of technology as well as innovation, Dr. Francis and Spine Associates has what may be the only Patient Ambassador Program for Spine Surgery patients. This program gives new spine surgery patients the opportunity to talk with someone who understands what they will be going through. When new patients are trying to decide about spine surgery as a treatment option it can be very helpful for them to connect with someone who has had a very similar experience. The Patient Ambassador Program was created by patients for patients and carefully matches new patients with former patients who have volunteered to share their experiences. For further information contact Spine Associates at 888-977-4625, Visit the website at www.myspineassociates.com or Ask The Doctor at www.myspineassociates.com/ask-the-doctor/
News Article | February 28, 2017
« Lorsqu'il s'agit de sélectionner la meilleure stratégie de greffe osseuse pour chaque patient, les chirurgiens peuvent choisir parmi de nombreuses options. BIOSPHERE PUTTY est une solution de greffe osseuse élégante qui est basée sur des principes scientifiquement valables », a déclaré Erik Westerlund MD, FACS, directeur du programme Ortho-Neuro Integrated Spine Surgery Program au St. Francis Hospital, aux États-Unis. « Il applique des connaissances avancées et pointues du verre bioactif en vue de stimuler une réaction ciblée au niveau cellulaire et de procurer un environnement physique idéal favorable à une régénération osseuse prévisible. Mon expérience clinique de BIOSPHERE PUTTY au cours des deux dernières années est excellente. J'obtiens régulièrement de bons résultats à long terme, dans une vaste gamme d'applications rachidiennes. C'est une solution osseuse extrêmement bien conçue et tout aussi polyvalente. » Fondée en 2011, Synergy Biomedical est une société privée de fabrication de dispositifs médicaux, spécialisée dans les produits innovateurs à base de biomatériaux pour les applications orthopédiques et rachidiennes. La technologie BioSphere de la société représente une approche unique visant à faire progresser la technologie en matière de greffe osseuse et à améliorer la guérison osseuse et les résultats pour le patient.